Bravo-Risi, Francisca
Soto, Paulina
Eckland, Thomas
Dittmar, Robert
RamÃrez, Santiago
Catumbela, Celso S. G.
Soto, Claudio
Lockwood, Mitch
Nichols, Tracy
Morales, Rodrigo
Funding for this research was provided by:
National Institutes of Health (P01 AI077774, R01AI132695)
U.S. Department of Agriculture (AP20VSSPRS00C143)
Article History
Received: 21 June 2021
Accepted: 30 August 2021
First Online: 15 September 2021
Competing interests
: R.M. is listed as an inventor in one patent related to the PMCA technology. C.S. is inventor on several patents related to the PMCA technology and is currently Founder, Chief Scientific Officer and Vice-President of Amprion Inc, a biotech company focusing on the commercial utilization of PMCA for diagnosis of various neurodegenerative diseases. F.B-R., PS, T.E., R.D., S.R., C.S.G.C., M.L. and T.N. have no conflicts to declare for this study.